Â鶹ֱ²¥
Â鶹ֱ²¥ & Lardner LLP served as legal counsel to United Theranostics, a leading provider of radiopharmaceutical therapy and supportive molecular imaging for cancer treatment, in its recent financing with Courage Capital.
United Theranostics is a national private practice dedicated to addressing the current major challenge of meaningful access to radiopharmaceutical therapy and advanced molecular imaging in community practice. The company will use proceeds from the financing to continue its mission of delivering the most effective, patient-centered therapies by combining state-of-the-art molecular imaging with tailored treatment plans.
The Â鶹ֱ²¥ health care transactions team, counsel to United Theranostics since its founding, was led by partners Roger Strode, Heidi Furlong, and Steve Gerenraich, senior counsel Melissa Conroy, and associate Mary Garner.
